About me

PhD, MBA, General Partner, member of the executive committee - Supernova InvestCelia Hart

Celia has more than 20 years’ experience in venture capital. She is a co-founder of Supernova Invest and is responsible for the early-stage investment team, the healthcare sector as well as the Supernova 2 and Supernova Innovation 3 funds.

Before joining Supernova Invest, Celia held several positions at Cambridge Antibody Technology (Medimmune since its acquisition by AstraZeneca), one of the stars of UK biotech.

She played a role in developing a number of therapeutic antibodies, including some in co-development with international industrial partners.

Celia is a member of the board of directors or supervisory board of several companies, including Cairdac, Carthera, Diabeloop, Keranova, NH Theraguix, Uromems, Acusurgical and Allotex.


About Celia Hart

Celia holds a master’s degree in chemistry from the University of Geneva (Switzerland), a PhD from the University of Oxford, and an MBA from Grenoble École de Management (France).


Michel Therin
DVM, PhD, Chairman of the BoardMichel Therin
Denise Hoblingre
CEODenise Hoblingre
Valérie Calenda
PhD, partner at Mérieux Développement Investment FundValérie Calenda
Philippe Tourrette
President Tourrette Investissement FundPhilippe Tourrette
Louis Geslin
PharmD, Observer - Financière Arbevel.Louis Geslin